Comparison of metalloproteinase protein and activity profiling

Orsi Giricz1, Janelle L Lauer, Gregg B Fields

  • 1Department of Chemistry and Biochemistry, Florida Atlantic University, Boca Raton, FL 33431, USA.

Analytical Biochemistry
|October 6, 2010
PubMed

Insights

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) are key in disease. This study quantified MMP/TIMP production and activity in cancer cell lines, revealing differences in secretion and functional activity.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Proteolytic enzymes, particularly matrix metalloproteinases (MMPs), are integral to biological processes.
  • MMPs are implicated in disease progression, making their study critical for understanding pathological mechanisms.

Purpose of the Study:

  • To quantify the production of MMPs and tissue inhibitors of metalloproteinases (TIMPs) in various cancer cell lines.
  • To assess the correlation between MMP/TIMP protein production and their enzymatic activity in specific cell lines.
  • To evaluate the utility of in situ fluorescence resonance energy transfer (FRET) substrate assays for studying metalloproteinase function.

Main Methods:

  • Utilized the ExcelArray Human MMP/TIMP Array to measure protein levels in cell lysates and media.
  • Employed matrix metalloproteinase (MMP) activity assays with three distinct fluorescence resonance energy transfer (FRET) substrates.
  • Used specific inhibitors to validate metalloproteinase activity observed in FRET assays.

Main Results:

  • MMP and TIMP production patterns were largely consistent between cell-associated and secreted fractions, with higher overall MMP levels in media.
  • Tissue inhibitor of metalloproteinase-1 (TIMP-1) was ubiquitously produced across all tested cell lines.
  • While both WM-266-4 and BJ cell lines showed general MMP activity, only BJ cells exhibited confirmed activity with a selective MMP substrate (NFF-3).

Conclusions:

  • Protein production levels do not always directly correlate with functional metalloproteinase activity.
  • In situ FRET assays provide valuable insights into metalloproteinase function but have limitations that necessitate confirmation with inhibitors.
  • The differential activity observed highlights the complexity of MMP regulation in cancer cells.